| Autor: |
Candy, David C A, Van Ampting, Marleen T J, Oude Nijhuis, Manon M, Wopereis, Harm, Butt, Assad M, Peroni, Diego G, Vandenplas, Yvan, Fox, Adam T, Shah, Neil, West, Christina E, Garssen, Johan, Harthoorn, Lucien F, Knol, Jan, Michaelis, Louise J |
| Zdroj: |
Pediatric Research; March 2018, Vol. 83 Issue: 3 p677-686, 10p |
| Abstrakt: |
BackgroundPrebiotics and probiotics (synbiotics) can modify gut microbiota and have potential in allergy management when combined with amino-acid-based formula (AAF) for infants with cow’s milk allergy (CMA).MethodsThis multicenter, double-blind, randomized controlled trial investigated the effects of an AAF-including synbiotic blend on percentages of bifidobacteria and Eubacterium rectale/Clostridium coccoides group (ER/CC) in feces from infants with suspected non-IgE-mediated CMA. Feces from age-matched healthy breastfed infants were used as reference (healthy breastfed reference (HBR)) for primary outcomes. The CMA subjects were randomized and received test or control formula for 8 weeks. Test formula was a hypoallergenic, nutritionally complete AAF including a prebiotic blend of fructo-oligosaccharides and the probiotic strain Bifidobacterium breve M-16V. Control formula was AAF without synbiotics.ResultsA total of 35 (test) and 36 (control) subjects were randomized; HBR included 51 infants. At week 8, the median percentage of bifidobacteria was higher in the test group than in the control group (35.4% vs. 9.7%, respectively; P<0.001), whereas ER/CC was lower (9.5% vs. 24.2%, respectively; P<0.001). HBR levels of bifidobacteria and ER/CC were 55% and 6.5%, respectively.ConclusionAAF including specific synbiotics, which results in levels of bifidobacteria and ER/CC approximating levels in the HBR group, improves the fecal microbiota of infants with suspected non-IgE-mediated CMA. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full text from SpringerLink